Call/webcast to feature updates on the discovery platform and pipeline, including updated data from the ongoing Phase 1b trial of ATRC-101SAN CARLOS, Calif., March 23, 2023 (GLOBE NEWSWIRE) Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biote.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
SAN CARLOS, Calif., Aug. 08, 2022 Atreca, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on. | August 8, 2022
Atreca to Present at Upcoming Investor Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.